TRPV4 in Regulation of Lung Endothelial Permeability
TRPV4 调节肺内皮通透性
基本信息
- 批准号:7897855
- 负责人:
- 金额:$ 30.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-24 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAgonistAlveolarArachidonic AcidsAttentionBlood VesselsBlood capillariesChronicConsensusCoronary arteryCorrosion CastingCytochrome P450DataDevelopmentDown-RegulationEndothelial CellsEndotheliumFingerprintFloodsGasesHeart failureHeatingHeterogeneityInjuryLigandsLinkLipidsLungMapsMeasuresMechanical StressMechanicsMediatingMicroscopyModelingMusPathway interactionsPatternPermeabilityPhenotypePhorbolPhorbolsProteinsRattusRegulationResearch PersonnelSignal PathwayStimulusStressTemperatureThapsigarginVanilloidWorkanandamidebasecapillaryextracellularinhibitor/antagonistmembernovelpressureprogramsreceptorresponsetool
项目摘要
We propose that acute lung injury paradigms are likely to be characterized by unique endothelial injury
"fingerprints" based on the Ca2+ entry pathways they target and the expression pattern of these channel
proteins. Members of the canonical subfamily of transient receptor potential (TRP) proteins comprise
subunits of store-operated Ca2+ channels and participate in Ca2+ entry-dependent regulation of lung
endothelial permeability in extra-alveolar vessels. Our observation that heart failure leads to loss of the
permeability response to store depletion but not that to 14,15-epoxyeicosatrienoic acid (14,15-EET), a lipid
that promotes Ca2+ entry-dependent acute lung injury only in alveolar septal capillaries, suggests that 14,15-
EET targets a distinct channel expressed in the septal microvasculature. Our preliminary data suggests a
novel candidate - TRPV4 - a member of the vanilloid subfamily of TRP proteins. We HYPOTHESIZE that
regulation of TRPV4 channels expressed in alveolar septal endothelium integrates the Ca2+ entry-dependent
permeability response to diverse stimuli, including heat, EETs, and high vascular pressure. Further, we
hypothesize that TRPV4-dependent permeability responses in septal capillary endothelium are independent
of store-operated Ca2+ entry pathways, and thus should be retained in chronic heart failure. AIM 1 will
determine whether TRPV4 is a common target by which EETs and mechanical perturbation promote Ca2+
influx required for increased endothelial permeability in the alveolar septal compartment of the lung, and
whether temperature sets the gain of this response. AIM 2 will reveal whether TRPV4-mediated endothelial
permeability responses in septal capillaries are retained in chronic heart failure, a model in which storeoperated
TRPC channels are down-regulated. We will address these aims using specific measures of
permeability and Ca2+ entry in isolated rat and mouse lung, microscopy of lung and vascular corrosion casts
to map spatial heterogeneity in the permeability response, pharmacological tools to manipulate signaling
pathways implicated in gating of TRPV4, and TRPV4-/- mice. This work will provide the first rigorous
analysis of TRPV4 channel expression linked to regulation of endothelial permeability in the intact lung
microvasculature.
我们认为急性肺损伤的典型特征可能是独特的内皮损伤
基于它们靶向的Ca 2+进入途径和这些通道的表达模式的“指纹”
proteins.瞬时受体电位(TRP)蛋白的典型亚家族的成员包括
钙池操纵的钙通道亚基,参与肺钙通道依赖性调节
肺泡外血管的内皮通透性。我们观察到心力衰竭会导致
渗透性对储存耗竭的反应,但对脂质14,15-环氧二十碳三烯酸(14,15-EET)的反应不明显
仅在肺泡隔毛细血管中促进Ca 2+进入依赖性急性肺损伤,提示14,15-
EET靶向中隔微血管中表达的独特通道。我们的初步数据显示
新的候选人-TRPV 4-TRP蛋白的香草素亚家族的成员。我们假设
在肺泡间隔内皮细胞中表达的TRPV 4通道的调节整合了Ca 2+进入依赖性的
渗透性对各种刺激的反应,包括热、Ehramidine和高血管压。我们还
假设隔毛细血管内皮中TRPV 4依赖性渗透性反应是独立的,
钙库操作的钙进入途径,因此应保留在慢性心力衰竭。AIM 1将
确定TRPV 4是否是Ehrs和机械扰动促进Ca 2+的共同靶点
肺肺泡隔室内皮通透性增加所需的内流,和
温度是否设置该响应的增益。AIM 2将揭示TRPV 4介导的内皮细胞
在慢性心力衰竭中,间隔毛细血管的渗透性反应得以保留,在该模型中,
TRPC通道下调。我们将通过以下具体措施来实现这些目标:
离体大鼠和小鼠肺的渗透性和Ca 2+进入、肺和血管腐蚀模型的显微镜检查
绘制渗透性反应的空间异质性,操纵信号传导的药理学工具
涉及TRPV 4门控的途径和TRPV 4-/-小鼠。这项工作将提供第一个严格的
与完整肺中内皮通透性调节相关的TRPV 4通道表达的分析
微脉管系统
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY I TOWNSLEY其他文献
MARY I TOWNSLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY I TOWNSLEY', 18)}}的其他基金
TRPV4 in Regulation of Lung Endothelial Permeability
TRPV4 调节肺内皮通透性
- 批准号:
7217674 - 财政年份:2006
- 资助金额:
$ 30.88万 - 项目类别:
TRPV4 in Regulation of Lung Endothelial Permeability
TRPV4 调节肺内皮通透性
- 批准号:
7074624 - 财政年份:2005
- 资助金额:
$ 30.88万 - 项目类别:
TRPV4 in Regulation of Lung Endothelial Permeability
TRPV4 调节肺内皮通透性
- 批准号:
6976874 - 财政年份:2005
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
7776845 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
8244456 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
6878603 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
7039201 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
7216188 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
7561767 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
Training in Cell Signaling and Lung Pathobiology
细胞信号传导和肺部病理学培训
- 批准号:
6748831 - 财政年份:2004
- 资助金额:
$ 30.88万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Fellowship














{{item.name}}会员




